CSI Market
Sign In | Register

Therapeutic Solutions International Inc (TSOI) Annual Income Statement

Annual · GAAP · USD millions
Access TSOI quarterly income statements →
From Therapeutic Solutions International Inc through Dec 31 2019, changes in Dec 31 2023's revenue and cost structure provide insight into profitability trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
2023 		(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Revenues
Sales of Products0.10
Total Revenue0.10
Costs & Expenses
Cost of Goods and Services Sold0.04
Gross Profit0.06
Selling, Administration, Marketing0.43
Research and Development Expense0.56
Other Operating Expense / -Income0.47
Legal Fees0.43
Total operating costs including COS2.09
Operating income / -loss-1.99
Interest Expense0.42
Net Interest (-)Expense / Income-0.42
Extinguishment of Debt-0.17
Gain (Loss) on Derivative Instruments, Net, Pretax-0.02
Other loss / -income0.04
Total costs & expenses2.32
Income & Taxes
Income / -loss before income taxes-2.22
Income taxes expenses / -benefit0.00
Income after income taxes-2.22
Income / -loss from continuing operations-2.22
Non-controlling interests-0.05
Net income / -loss-2.22
Income / -loss to shareholder-2.17
EBIT-1.80
EBITD-1.79
EBITDA-1.10
Earnings Per Share
Basic EPS (excl. extra items)0.00
Basic Net EPS0.00
Basic shares outstanding (Mill. of Units)3,168.90
Diluted Net EPS0.00
Diluted average shares (Mill. of Units)3,168.90
4 historic quarters locked

Sign in to unlock the full Therapeutic Solutions International Inc income statement history.

Sign In Create Free Account

About Therapeutic Solutions International Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: April 17, 2024
  • Original filing: form10-k.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.